A novel candidate biomarker for detecting premalignant and early ovarian cancer
New data suggest that the long noncoding RNA known as Tu-Stroma represents a promising new circulating biomarker for the detection of ovarian cancer at premalignant and early stages, for which sensitive screening methods currently are lacking.